| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | GENB | United States | $12.78 | $0.00 | Strong Buy | 6 | N/A |
#2 | PARR | United States | $56.74 | $2,443,066,000.00 | Buy | 6 | 2000 |
#3 | AR | United States | $35.97 | $5,275,823,000.00 | Buy | 16 | 2013 |
#4 | INVA | United States | $21.75 | $217,217,000.00 | Buy | 5 | 2000 |
#5 | EQT | United States | $54.98 | $8,644,211,000.00 | Buy | 21 | 1994 |
#6 | NFG | United States | $78.09 | $2,277,541,000.00 | Buy | 4 | 1997 |
#7 | CVNA | United States | $72.03 | $20,322,000,000.00 | Buy | 24 | 2017 |
#8 | TMDX | United States | $66.51 | $605,494,000.00 | Buy | 9 | 2019 |
#9 | DEC | United States | $14.52 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#10 | TBPH | United States | $16.22 | $15,386,000.00 | Buy | 6 | 2013 |
#11 | GPOR | United States | $170.35 | $1,422,583,000.00 | Buy | 11 | 1998 |
#12 | VIAV | United States | $46.72 | $1,084,300,000.00 | Strong Buy | 8 | 1996 |
#13 | KNSA | United Kingdom | $49.06 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#14 | GLW | United States | $176.65 | $15,629,000,000.00 | Buy | 12 | 2008 |
#15 | EYE | United States | $16.80 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#16 | VTR | United States | $84.05 | $5,833,980,000.00 | Buy | 13 | 2005 |
#17 | AORT | United States | $22.79 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#18 | KNTK | United States | $45.89 | $160,617,000.00 | Buy | 12 | 2017 |
#19 | CALX | United States | $39.35 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#20 | APEI | United States | $50.21 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#21 | SWX | United States | $86.20 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#22 | SPHR | United States | $134.40 | $1,220,045,000.00 | Strong Buy | 12 | 2019 |
#23 | NVST | United States | $23.61 | $2,566,500,000.00 | Buy | 13 | 2019 |
#24 | PUMP | United States | $15.17 | $1,269,158,000.00 | Buy | 7 | 2017 |
#25 | NMRK | United States | $14.23 | $3,294,024,000.00 | Buy | 5 | 2017 |
#26 | ALHC | United States | $15.42 | $3,948,719,000.00 | Buy | 8 | 2021 |
#27 | JCI | Ireland | $136.43 | $9,902,000,000.00 | Buy | 16 | 2007 |
#28 | OMER | United States | $10.87 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#29 | ANAB | United States | $56.04 | $234,603,000.00 | Buy | 12 | 2015 |
#30 | PTEN | United States | $11.20 | $4,826,624,000.00 | Buy | 10 | 1995 |
#31 | AAOI | United States | $157.15 | $0.00 | Buy | 6 | 2013 |
#32 | CCK | United States | $96.23 | $11,665,000,000.00 | Buy | 16 | 2003 |
#33 | REPX | United States | $33.59 | $3,038,000.00 | Strong Buy | 4 | 2003 |
#34 | WCN | Canada | $149.78 | $9,466,915,000.00 | Buy | 19 | 2005 |
#35 | AROC | United States | $33.95 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#36 | PRVA | United States | $21.69 | $2,122,842,000.00 | Buy | 12 | 2021 |
#37 | LASR | United States | $72.26 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#38 | TW | United States | $99.52 | $892,659,000.00 | Buy | 12 | 2019 |
#39 | PLMR | United States | $108.56 | $875,967,000.00 | Buy | 5 | 2019 |
#40 | ETR | United States | $109.24 | $12,946,686,000.00 | Buy | 18 | 2005 |
#41 | KGS | United States | $67.60 | $1,308,100,000.00 | Strong Buy | 7 | 2023 |
#42 | BSX | United States | $49.18 | $9,076,000,000.00 | Strong Buy | 22 | 2010 |
#43 | CSV | United States | $42.32 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#44 | SDRL | United States | $47.73 | $1,437,000,000.00 | Buy | 4 | 2018 |
#45 | HG | Bermuda | $29.92 | $2,905,524,000.00 | Buy | 8 | 2023 |
#46 | PAY | United States | $23.12 | $1,196,507,000.00 | Buy | 8 | 2021 |
#47 | TARS | United States | $59.39 | $451,360,000.00 | Buy | 6 | 2020 |
#48 | CRVS | United States | $12.12 | $0.00 | Strong Buy | 6 | 2016 |
#49 | USFD | United States | $81.72 | $39,424,000,000.00 | Buy | 11 | 2016 |
#50 | PHAT | United States | $10.25 | $175,110,000.00 | Strong Buy | 6 | 2019 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $200 to Buy (May 29, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.